Tata Chemicals Intrinsic Value
Tata Chemicals (TATACHEM) median intrinsic value is ₹462.01 from 4 valuation models (range ₹314–₹870), vs current price ₹685.35 — -32.6% downside (Trading Above Calculated Value), margin of safety -48.3%. For current market price and key ratios, visit Tata Chemicals share price today.
TATACHEM Valuation Methods Summary — DCF, Graham Number & P/E
Tata Chemicals intrinsic value across 4 models vs current price ₹685.35 — upside/downside and value range per method. Read TATACHEM dividend yield for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹869.61 | ₹782.65 - ₹956.57 | +26.9% | Book Value/Share: ₹869.61, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹441.10 | ₹396.99 - ₹485.21 | -35.6% | Revenue/Share: ₹551.37, P/S: 0.8x |
| Simple DCF (5Y) | dcf | ₹462.01 | ₹369.61 - ₹554.41 | -32.6% | CF Growth: 5.0%, Discount: 15% |
| Dividend Yield Method | dividend | ₹314.29 | ₹282.86 - ₹345.72 | -54.1% | DPS: ₹11.00, Target Yield: 3.5% |
TATACHEM Intrinsic Value vs Market Price — All Valuation Models
Tata Chemicals fair value range ₹314–₹870 vs current market price ₹685.35 across 4 valuation models. Analyse Tata Chemicals shareholding analysis to track promoter, FII and institutional holdings.
TATACHEM Intrinsic Value Analysis — Undervalued or Overvalued?
Tata Chemicals median intrinsic value ₹462.01, current price ₹685.35 — Trading Above Calculated Value by 32.6%, margin of safety -48.3%.
What is the intrinsic value of TATACHEM?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Tata Chemicals (TATACHEM) is ₹462.01 (median value). With the current market price of ₹685.35, this represents a -32.6% variance from our estimated fair value.
The valuation range spans from ₹314.29 to ₹869.61, indicating ₹314.29 - ₹869.61.
Is TATACHEM undervalued or overvalued?
Based on our multi-method analysis, Tata Chemicals (TATACHEM) appears to be trading above calculated value by approximately 32.6%.
TATACHEM Financial Health — Key Ratios vs Industry Benchmarks
Tata Chemicals financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.71 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | -38.2% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -45.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.36x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
TATACHEM Cash Flow Quality — Operating & Free Cash Flow
Tata Chemicals operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹1,269 Cr | ₹886 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹1,761 Cr | ₹928 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹3,016 Cr | ₹2,714 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹2,971 Cr | ₹2,397 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹1,644 Cr | ₹1,236 Cr | Positive Free Cash Flow | 8/10 |